TipRanks
Compagnie de Saint-Gobain SA (CODGF)
OTHER OTC:CODGF
US Market
EarningsQ2 2026 Earnings Report

Compagnie de Saint Gobain (CODGF) Q2 2026 Earnings Report

3 Followers

CODGF Q2 2026 EPS Results

Actual EPS$3.97
Consensus EPS$3.62
Beat/MissBeat by +$0.35
One Year Ago EPS$4.19

CODGF Q2 2026 Revenue Results

Actual Revenue$27.23B
Expected Revenue$14.06B
Beat/MissBeat by +$13.17B
YoY Revenue Growth-1.08%

Earnings Announcement Details

QuarterQ2 2026
Date07/30/2026
TimeAfter Close
Conference CallThursday, July 30, 2026
CODGF Upcoming Earnings
Compagnie de Saint Gobain's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents a broadly positive operational and strategic picture: underlying growth accelerated in Q2 across regions, profitability (EBITDA margin 15.4%) and cash generation were strong, and management executed active portfolio rotation and targeted investment in high-growth markets and construction chemicals. Offsetting risks include forex headwinds, a slightly negative H1 price-cost spread (with only a slight positive expected for the full year), regional pockets of softness (Latin America, North American new construction) and input-cost inflation that requires continued price realization. On balance, the positive items (growth acceleration, margins, cash, M&A and capacity expansion) materially outweigh the challenges cited.
Company Guidance
The group guided to continued like‑for‑like growth in H2 after delivering +0.7% LFL in H1 (Q2 +3.5% organic), with construction chemicals particularly strong (Q2 organic +8.5%); H1 metrics included an EBITDA margin of 15.4% (management expects >15% for 2026), recurring net income of EUR 1.7bn, free cash flow of EUR 2.1bn (cash conversion 65% of EBITDA and 125% of recurring net income), operating working capital at 24 days, CapEx expected around EUR 2bn for the full year, net debt ratio 1.6x and ROCE 13.5% in local currencies (FX‑diluted in actuals). Management reiterated a target for a slight positive price‑cost spread for 2026 after prices +0.8% in H1 (Q2 +1.6%), noted FX headwinds of -1.3% and structural -0.5% in H1, depreciation +3%, EPS -2.6% in LC, a 25% recurring tax rate, ~75% energy hedging for 2026 (energy <4% of sales), ~EUR 3bn of sales rotated YTD via 23 transactions (one‑third of the >20% by‑2030 rotation target), and EUR 1.4bn returned to shareholders in H1 (including EUR 292m buybacks).
Top-line Growth and Q2 Acceleration
Group like-for-like sales up 0.7% in H1 2026, with a stronger Q2 acceleration of +3.5% like-for-like; Asia Pacific +7% like-for-like in H1 and Europe returned to growth (+1.7% LFL H1, Q2 +4.1%).
Strong Profitability
EBITDA margin reached 15.4% in H1 2026 and management reiterates an EBITDA margin target of >15% for full-year 2026.
Robust Recurring Net Income and EPS Context
Recurring net income of EUR 1.7 billion in H1 2026; EPS fell modestly (-2.6% in local currencies) while recurring net income remained strong.
Very Strong Free Cash Flow and Conversion
Generated EUR 2.1 billion free cash flow in H1 with cash conversion at 65% of EBITDA and 125% of recurring net income; operating working capital stable at 24 days and net debt ratio at 1.6x.
Construction Chemicals Outperformance
Construction chemicals strongly outperformed with +8.5% organic sales growth in Q2 and significant market traction in India, Southeast Asia and North America.
Capital Allocation and Portfolio Rotation
23 acquisitions and divestments signed/closed in H1; around EUR 3 billion of sales rotated year-to-date (≈ one-third of the >20% sales rotation target to 2030); announced bolt-on acquisitions such as Xypex and AGC Polymer Materials.
Investment in Growth and Capacity
Opened 13 of 14 planned new lines/plants in H1 across North America, Asia and emerging markets; ~90% of gross CapEx and M&A deployed in high-growth regions.
Regional Margin Strength
Americas delivered an EBITDA margin of 19.5% (stable vs H2 2025) and Asia Pacific achieved a record region EBITDA margin of 18.5%, supported by volume and pricing.

CODGF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Mar 04, 2027
2026 (Q4)
3.51 / -
3.543
2026 (Q2)
3.62 / 3.97
4.189-5.23% (-0.22)
2025 (Q4)
3.40 / 3.54
2.7528.83% (+0.79)
2025 (Q2)
4.19 / 4.19
3.9236.76% (+0.27)
2024 (Q4)
- / 2.75
3.335-17.54% (-0.59)
2024 (Q2)
- / 3.92
4.12-4.76% (-0.20)
2023 (Q4)
3.47 / 3.33
3.427-2.69% (-0.09)
Jul 26, 2023
2023 (Q2)
- / 4.12
4.051.71% (+0.07)
2022 (Q4)
3.33 / 3.43
2.89118.56% (+0.54)
2022 (Q2)
3.35 / 4.05
3.28923.16% (+0.76)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed